CAVO, MICHELE
CAVO, MICHELE
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Radiologic findings of Fusarium pneumonia in neutropenic patients
In corso di stampa Sassi, Claudia; Stanzani, Marta; Lewis, Russell E.; Vianelli, Nicola; Tarsi, Andrea; Poerio, Antonio; Cavo, Michele; Battista, Giuseppe
A multicenter observational retrospective study of second-line treatment with daratumumab–bortezomib–dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide
2026 Rizzello, I.; Sacchetti, I.; Barbato, S.; Solli, V.; Stefanoni, P.; Cani, L.; Quaresima, M.; Belotti, A.; Sgherza, N.; Gentile, M.; Zambello, R.; Barilà, G.; Celli, M.; Mele, G.; Mancuso, K.; Pantani, L.; Tacchetti, P.; Talarico, M.; Puppi, M.; Manzato, E.; Restuccia, R.; Masci, S.; Ghibellini, S.; Bigi, F.; Cavo, M.; Zamagni, E.
Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study
2026 Beksac, M.; Firatli Tuglular, T.; Gay, F.; Mina, R.; Katodritou, E.; Unal, A.; Cavo, M.; Ozsan, G. H.; Van Der Velden, V. H. J.; Beverloo, B. H.; Vermeulen, M.; Van Duin, M.; Seval, G. C.; Sevindik, O. G.; Merante, S.; Manousou, K.; Sonneveld, P.; Zamagni, E.; Terpos, E.
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma
2025 Talarico, Marco; Vischini, Gisella; Barbato, Simona; Restuccia, Roberta; Masci, Simone; Sacchetti, Ilaria; Manzato, Enrica; Ghibellini, Stefano; Puppi, Michele; Iezza, Miriam; Rizzello, Ilaria; Pantani, Lucia; Tacchetti, Paola; Borsi, Enrica; Solli, Vincenza; Terragna, Carolina; Agostinelli, Claudio; La Manna, Gaetano; Cavo, Michele; Zamagni, Elena; Mancuso, Katia
Correction: Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
2025 Mancuso, K.; Barbato, S.; Raimondo, F. D.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zamagni, E.; Zambello, R.; Cavo, M.
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma
2025 Talarico, M.; Barbato, S.; Cattabriga, A.; Sacchetti, I.; Manzato, E.; Restuccia, R.; Masci, S.; Bigi, F.; Puppi, M.; Iezza, M.; Rizzello, I.; Mancuso, K.; Pantani, L.; Tacchetti, P.; Nanni, C.; Cavo, M.; Zamagni, E.
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
2025 Dimopoulos, M. A.; Terpos, E.; Boccadoro, M.; Moreau, P.; Mateos, M. -V.; Zweegman, S.; Cook, G.; Engelhardt, M.; Delforge, M.; Hajek, R.; Schjesvold, F.; Gay, F.; Manier, S.; Weisel, K. C.; Kaiser, M.; Van De Donk, N. W. C. J.; Zamagni, E.; Rodriguez-Otero, P.; Perrot, A.; Driessen, C.; Bila, J.; Laane, E.; Dytfeld, D.; Touzeau, C.; Beksac, M.; Raab, M. S.; Cavo, M.; Mohty, M.; Spencer, A.; Ludwig, H.; Einsele, H.; San-Miguel, J.; Sonneveld, P.
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
2025 Bolli, N.; D'Agostino, M.; Bagratuni, T.; Boccadoro, M.; Cavo, M.; Driessen, C.; Einsele, H.; Engelhardt, M.; Gay, F.; Gutierrez, N. C.; Hajek, R.; Holien, T.; Joao, C.; Kaiser, M.; Kortum, K. M.; Leypoldt, L.; Moreau, P.; Musto, P.; Ocio, E. M.; Raab, M. S.; Rasche, L.; Schjesvold, F.; Sevcikova, T.; Terpos, E.; Touzeau, C.; Van De Donk, N. W. C. J.; Van Duin, M.; Weisel, K.; Zamagni, E.; Cupedo, T.; Sonneveld, P.; Terragna, C.
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
2025 Musto, P.; Engelhardt, M.; van de Donk, N. W. C. J.; Gay, F.; Terpos, E.; Einsele, H.; Fernández de Larrea, C.; Sgherza, N.; Bolli, N.; Katodritou, E.; Gentile, M.; Royer, B.; Derudas, D.; Jelinek, T.; Zamagni, E.; Rosiñol, L.; Paiva, B.; Caers, J.; Kaiser, M.; Beksac, M.; Hájek, R.; Spencer, A.; Ludwig, H.; Cavo, M.; Bladé, J.; Moreau, P.; Mateos, M. V.; San-Miguel, J. F.; Dimopoulos, M. A.; Boccadoro, M.; Sonneveld, P.
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
2025 Talarico, M.; Barbato, S.; Maisnar, V.; Delimpasi, S.; Puppi, M.; Rizzello, I.; Pantani, L.; Tacchetti, P.; Martello, M.; Vigliotta, I.; Terragna, C.; Cavo, M.; Zamagni, E.; Mancuso, K.
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
2025 Mancuso, K.; Barbato, S.; Di Raimondo, F.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zamagni, E.; Zambello, R.; Cavo, M.
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
2025 Salvestrini, Valentina; Conti, Gabriele; D'Amico, Federica; Cristiano, Gianluca; Candela, Marco; Cavo, Michele; Turroni, Silvia; Curti, Antonio
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma
2025 Mancuso, Katia; Barbato, Simona; Talarico, Marco; Tacchetti, Paola; Zamagni, Elena; Cavo, Michele
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform
2025 Mosquera Orgueira, A.; Gonzalez Perez, M. S.; D'Agostino, M.; Cairns, D. A.; Larocca, A.; Palacios, J. J. L.; Wester, R.; Bertsch, U.; Waage, A.; Zamagni, E.; Perez Miguez, C.; Rojas Martinez, J. A.; Mai, E. K.; Crucitti, D.; Salwender, H.; Dall'Olio, D.; Castellani, G.; Pineiro Fiel, M.; Bringhen, S.; Zweegman, S.; Cavo, M.; Iqbal, S.; Hernandez Rivas, J. M.; Bruno, B.; Cook, G.; Kaiser, M. F.; Goldschmidt, H.; Van De Donk, N. W. C. J.; Jackson, G.; San-Miguel, J. F.; Boccadoro, M.; Mateos, M. -V.; Sonneveld, P.
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor
2025 Ocadlikova, D.; Fiordi, B.; Trabanelli, S.; Salvestrini, V.; Ciciarello, M.; Forte, D.; Campazzi, E.; Vitali, L.; Cipollitta, S. C.; Pegoraro, A.; Jandus, C.; Di Virgilio, F.; Adinolfi, E.; Cavo, M.; Curti, A.
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability
2025 Mancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Castagnetti, Fausto; Iezza, Miriam; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Cerrano, Marco; Capodanno, Isabella; Bonifacio, Massimiliano; Rossi, Maura; Agostinelli, Claudio; Meggendorfer, Manja; Haferlach, Torsten; Cavo, Michele; Gugliotta, Gabriele; Soverini, Simona
Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework
2025 Boccadoro, M.; Belotti, A.; Bombaci, F.; Bringhen, S.; Buda, G.; Cafro, A. M.; Caimmi, M.; Canali, B.; Canonico, P. L.; Cavo, M.; Corso, A.; De Paoli, L.; Derudas, D.; Di Raimondo, F.; Galeone, C.; Gay, F.; Gentile, M.; Giuliani, N.; La Malfa, P.; Mercati, R.; Montefusco, V.; Musto, P.; Offidani, M.; Patriarca, F.; Petrucci, M. T.; Riccaboni, M.; Tosi, P.; Zamagni, E.; Zambello, R.; Fiorentino, F.
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS
2025 Mancuso, K.; Talarico, M.; Manzato, E.; Barbato, S.; Tacchetti, P.; Zamagni, E.; Cavo, M.
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home
2025 Bigi, F.; Fiacchini, M.; Restuccia, R.; Masci, S.; Mazzocchetti, G.; Talarico, M.; Puppi, M.; Sacchetti, I.; Manzato, E.; Iezza, M.; Mancuso, K.; Sartor, C.; Pantani, L.; Tacchetti, P.; Alatif, R. A.; Pastore, E.; Barbato, S.; Cavo, M.; Zamagni, E.; Rizzello, I.
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma
2025 Poletti, A; Taurisano, B; Mazzocchetti, G; Lionetti, M; Martello, M; Vuong, Vm; Solli, V; Marzocchi, G; Maeda, A; Vigliotta, I; Borsi, E; Armuzzi, S; Pistis, I; Marella, A; Fabris, S; Tacchetti, P; Mancuso, K; Rizzello, I; Pantani, L; Testoni, N; Cavo, M; Zamagni, E; Bolli, N; Terragna, C.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Radiologic findings of Fusarium pneumonia in neutropenic patients | Sassi, Claudia; Stanzani, Marta; Lewis, Russell E.; Vianelli, Nicola; Tarsi, Andrea; Poerio, Anto...nio; Cavo, Michele; Battista, Giuseppe | 9999-01-01 | MYCOSES | - | 1.01 Articolo in rivista | - |
| A multicenter observational retrospective study of second-line treatment with daratumumab–bortezomib–dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide | Rizzello, I.; Sacchetti, I.; Barbato, S.; Solli, V.; Stefanoni, P.; Cani, L.; Quaresima, M.; Belo...tti, A.; Sgherza, N.; Gentile, M.; Zambello, R.; Barilà, G.; Celli, M.; Mele, G.; Mancuso, K.; Pantani, L.; Tacchetti, P.; Talarico, M.; Puppi, M.; Manzato, E.; Restuccia, R.; Masci, S.; Ghibellini, S.; Bigi, F.; Cavo, M.; Zamagni, E. | 2026-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | unpaywall-bitstream--599418026.pdf |
| Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study | Beksac, M.; Firatli Tuglular, T.; Gay, F.; Mina, R.; Katodritou, E.; Unal, A.; Cavo, M.; Ozsan, G.... H.; Van Der Velden, V. H. J.; Beverloo, B. H.; Vermeulen, M.; Van Duin, M.; Seval, G. C.; Sevindik, O. G.; Merante, S.; Manousou, K.; Sonneveld, P.; Zamagni, E.; Terpos, E. | 2026-01-01 | HEMASPHERE | - | 1.01 Articolo in rivista | - |
| Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma | Talarico, Marco; Vischini, Gisella; Barbato, Simona; Restuccia, Roberta; Masci, Simone; Sacchetti..., Ilaria; Manzato, Enrica; Ghibellini, Stefano; Puppi, Michele; Iezza, Miriam; Rizzello, Ilaria; Pantani, Lucia; Tacchetti, Paola; Borsi, Enrica; Solli, Vincenza; Terragna, Carolina; Agostinelli, Claudio; La Manna, Gaetano; Cavo, Michele; Zamagni, Elena; Mancuso, Katia | 2025-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-15-1672690.pdf |
| Correction: Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma | Mancuso, K.; Barbato, S.; Raimondo, F. D.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zam...agni, E.; Zambello, R.; Cavo, M. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-02555.pdf |
| Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma | Talarico, M.; Barbato, S.; Cattabriga, A.; Sacchetti, I.; Manzato, E.; Restuccia, R.; Masci, S.; ...Bigi, F.; Puppi, M.; Iezza, M.; Rizzello, I.; Mancuso, K.; Pantani, L.; Tacchetti, P.; Nanni, C.; Cavo, M.; Zamagni, E. | 2025-01-01 | JOURNAL OF BONE ONCOLOGY | - | 1.01 Articolo in rivista | 1-s2.0-S2212137425000107-main.pdf |
| EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma | Dimopoulos, M. A.; Terpos, E.; Boccadoro, M.; Moreau, P.; Mateos, M. -V.; Zweegman, S.; Cook, G.;... Engelhardt, M.; Delforge, M.; Hajek, R.; Schjesvold, F.; Gay, F.; Manier, S.; Weisel, K. C.; Kaiser, M.; Van De Donk, N. W. C. J.; Zamagni, E.; Rodriguez-Otero, P.; Perrot, A.; Driessen, C.; Bila, J.; Laane, E.; Dytfeld, D.; Touzeau, C.; Beksac, M.; Raab, M. S.; Cavo, M.; Mohty, M.; Spencer, A.; Ludwig, H.; Einsele, H.; San-Miguel, J.; Sonneveld, P. | 2025-01-01 | NATURE REVIEWS. CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma | Bolli, N.; D'Agostino, M.; Bagratuni, T.; Boccadoro, M.; Cavo, M.; Driessen, C.; Einsele, H.; Eng...elhardt, M.; Gay, F.; Gutierrez, N. C.; Hajek, R.; Holien, T.; Joao, C.; Kaiser, M.; Kortum, K. M.; Leypoldt, L.; Moreau, P.; Musto, P.; Ocio, E. M.; Raab, M. S.; Rasche, L.; Schjesvold, F.; Sevcikova, T.; Terpos, E.; Touzeau, C.; Van De Donk, N. W. C. J.; Van Duin, M.; Weisel, K.; Zamagni, E.; Cupedo, T.; Sonneveld, P.; Terragna, C. | 2025-01-01 | HEMASPHERE | - | 1.01 Articolo in rivista | - |
| European Myeloma Network Group review and consensus statement on primary plasma cell leukemia | Musto, P.; Engelhardt, M.; van de Donk, N. W. C. J.; Gay, F.; Terpos, E.; Einsele, H.; Fernández ...de Larrea, C.; Sgherza, N.; Bolli, N.; Katodritou, E.; Gentile, M.; Royer, B.; Derudas, D.; Jelinek, T.; Zamagni, E.; Rosiñol, L.; Paiva, B.; Caers, J.; Kaiser, M.; Beksac, M.; Hájek, R.; Spencer, A.; Ludwig, H.; Cavo, M.; Bladé, J.; Moreau, P.; Mateos, M. V.; San-Miguel, J. F.; Dimopoulos, M. A.; Boccadoro, M.; Sonneveld, P. | 2025-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | musto_2025.pdf |
| Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies? | Talarico, M.; Barbato, S.; Maisnar, V.; Delimpasi, S.; Puppi, M.; Rizzello, I.; Pantani, L.; Tacc...hetti, P.; Martello, M.; Vigliotta, I.; Terragna, C.; Cavo, M.; Zamagni, E.; Mancuso, K. | 2025-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | s00432-025-06326-3.pdf |
| Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma | Mancuso, K.; Barbato, S.; Di Raimondo, F.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zam...agni, E.; Zambello, R.; Cavo, M. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-01168-v2.pdf |
| Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients | Salvestrini, Valentina; Conti, Gabriele; D'Amico, Federica; Cristiano, Gianluca; Candela, Marco; ...Cavo, Michele; Turroni, Silvia; Curti, Antonio | 2025-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cancer Medicine - 2025 - Salvestrini - Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction.pdf |
| Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma | Mancuso, Katia; Barbato, Simona; Talarico, Marco; Tacchetti, Paola; Zamagni, Elena; Cavo, Michele | 2025-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | Idecabtagene vicleucel ide-cel for the treatment of triple-class exposed relapsed and refractory multiple myeloma.pdf |
| Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform | Mosquera Orgueira, A.; Gonzalez Perez, M. S.; D'Agostino, M.; Cairns, D. A.; Larocca, A.; Palacio...s, J. J. L.; Wester, R.; Bertsch, U.; Waage, A.; Zamagni, E.; Perez Miguez, C.; Rojas Martinez, J. A.; Mai, E. K.; Crucitti, D.; Salwender, H.; Dall'Olio, D.; Castellani, G.; Pineiro Fiel, M.; Bringhen, S.; Zweegman, S.; Cavo, M.; Iqbal, S.; Hernandez Rivas, J. M.; Bruno, B.; Cook, G.; Kaiser, M. F.; Goldschmidt, H.; Van De Donk, N. W. C. J.; Jackson, G.; San-Miguel, J. F.; Boccadoro, M.; Mateos, M. -V.; Sonneveld, P. | 2025-01-01 | HEMASPHERE | - | 1.01 Articolo in rivista | - |
| Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor | Ocadlikova, D.; Fiordi, B.; Trabanelli, S.; Salvestrini, V.; Ciciarello, M.; Forte, D.; Campazzi,... E.; Vitali, L.; Cipollitta, S. C.; Pegoraro, A.; Jandus, C.; Di Virgilio, F.; Adinolfi, E.; Cavo, M.; Curti, A. | 2025-01-01 | JOURNAL OF LEUKOCYTE BIOLOGY | - | 1.01 Articolo in rivista | qiaf010.pdf; qiaf010_supplementary_data.doc |
| SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability | Mancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Castagnetti, Fausto; Iezza, Miriam; Iurlo, A...lessandra; Cattaneo, Daniele; Galimberti, Sara; Cerrano, Marco; Capodanno, Isabella; Bonifacio, Massimiliano; Rossi, Maura; Agostinelli, Claudio; Meggendorfer, Manja; Haferlach, Torsten; Cavo, Michele; Gugliotta, Gabriele; Soverini, Simona | 2025-01-01 | CLINICAL AND TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | - |
| Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework | Boccadoro, M.; Belotti, A.; Bombaci, F.; Bringhen, S.; Buda, G.; Cafro, A. M.; Caimmi, M.; Canali..., B.; Canonico, P. L.; Cavo, M.; Corso, A.; De Paoli, L.; Derudas, D.; Di Raimondo, F.; Galeone, C.; Gay, F.; Gentile, M.; Giuliani, N.; La Malfa, P.; Mercati, R.; Montefusco, V.; Musto, P.; Offidani, M.; Patriarca, F.; Petrucci, M. T.; Riccaboni, M.; Tosi, P.; Zamagni, E.; Zambello, R.; Fiorentino, F. | 2025-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | - |
| T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS | Mancuso, K.; Talarico, M.; Manzato, E.; Barbato, S.; Tacchetti, P.; Zamagni, E.; Cavo, M. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-01514.pdf |
| Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home | Bigi, F.; Fiacchini, M.; Restuccia, R.; Masci, S.; Mazzocchetti, G.; Talarico, M.; Puppi, M.; Sac...chetti, I.; Manzato, E.; Iezza, M.; Mancuso, K.; Sartor, C.; Pantani, L.; Tacchetti, P.; Alatif, R. A.; Pastore, E.; Barbato, S.; Cavo, M.; Zamagni, E.; Rizzello, I. | 2025-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | s10238-025-01683-2.pdf; 10238_2025_1683_MOESM1_ESM.docx |
| Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma | Poletti, A; Taurisano, B; Mazzocchetti, G; Lionetti, M; Martello, M; Vuong, Vm; Solli, V; Marzocc...hi, G; Maeda, A; Vigliotta, I; Borsi, E; Armuzzi, S; Pistis, I; Marella, A; Fabris, S; Tacchetti, P; Mancuso, K; Rizzello, I; Pantani, L; Testoni, N; Cavo, M; Zamagni, E; Bolli, N; Terragna, C. | 2025-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 12063-Article+Text-87603-1-10-20250515.pdf |